Legis Daily

Protect Patient Access to Pharmacies Act

USA118th CongressS-2052| Senate 
| Updated: 6/20/2023
Jon Tester

Jon Tester

Democratic Senator

Montana

Cosponsors (3)
James Lankford (Republican)Sherrod Brown (Democratic)Shelley Moore Capito (Republican)

Finance Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Protect Patient Access to Pharmacies Act This bill establishes certain requirements with respect to payments to pharmacies by prescription drug plan (PDP) sponsors under the Medicare prescription drug benefit and Medicare Advantage. Specifically, the Centers for Medicare & Medicaid Services (CMS) must ensure that payments sufficiently cover a pharmacy's costs to acquire and dispense covered drugs so as to enable the pharmacy to participate as a network provider. The CMS must (1) use relevant data from pharmacies with respect to acquisition and dispensing costs for covered drugs, (2) establish payment parameters, and (3) establish an appeal process for pharmacies about payments. The CMS must also evaluate the performance measures used by PDP sponsors for pharmacy price concessions or other performance fees and develop standardized performance measures.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 20, 2023
Introduced in Senate
Jun 20, 2023
Read twice and referred to the Committee on Finance.
  • June 20, 2023
    Introduced in Senate


  • June 20, 2023
    Read twice and referred to the Committee on Finance.

Health

Protect Patient Access to Pharmacies Act

USA118th CongressS-2052| Senate 
| Updated: 6/20/2023
Protect Patient Access to Pharmacies Act This bill establishes certain requirements with respect to payments to pharmacies by prescription drug plan (PDP) sponsors under the Medicare prescription drug benefit and Medicare Advantage. Specifically, the Centers for Medicare & Medicaid Services (CMS) must ensure that payments sufficiently cover a pharmacy's costs to acquire and dispense covered drugs so as to enable the pharmacy to participate as a network provider. The CMS must (1) use relevant data from pharmacies with respect to acquisition and dispensing costs for covered drugs, (2) establish payment parameters, and (3) establish an appeal process for pharmacies about payments. The CMS must also evaluate the performance measures used by PDP sponsors for pharmacy price concessions or other performance fees and develop standardized performance measures.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 20, 2023
Introduced in Senate
Jun 20, 2023
Read twice and referred to the Committee on Finance.
  • June 20, 2023
    Introduced in Senate


  • June 20, 2023
    Read twice and referred to the Committee on Finance.
Jon Tester

Jon Tester

Democratic Senator

Montana

Cosponsors (3)
James Lankford (Republican)Sherrod Brown (Democratic)Shelley Moore Capito (Republican)

Finance Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted